𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Temporary worsening of parkinsonism in a patient with Parkinson's disease after treatment with paclitaxel for a metastatic grade IV adenocarcinoma

✍ Scribed by James H. Bower; Manfred D. Muenter


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
232 KB
Volume
10
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Worsening of motor symptoms and gynecoma
✍ HΓ©lio A.G. Teive; Renato P. Munhoz; Lineu C. Werneck πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 42 KB πŸ‘ 1 views

roradiological features beyond the typical cerebellar peduncle hyperintensities that were found minimal in this instance. FXTAS is expected to be less severe in females because of the presence of two X chromosomes, subject to random inactivation. It has been suggested that expression of the disease

Akathisia as a side effect of antipsycho
✍ Christian Prueter; Benedikt Habermeyer; Christine Norra; Christoph M. Kosinski πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 43 KB πŸ‘ 1 views

## Abstract Due to its low profile for extrapyramidal side‐effects, quetiapine has become an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease (PD). We describe the case of a patient with PD who developed severe akathisia, a common complication

Cueing for freezing of gait in patients
✍ Alice Nieuwboer πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 1 views

Freezing of gait (FOG) has been known to respond favorably to sensory tricks and cues. However, FOG is a complex phenomenon with various motor control deficits at play. In this review, we examined and summarized the currently available evidence for the effectiveness of cueing for FOG to determine it

Validation of a swallowing disturbance q
✍ Yael Manor; Nir Giladi; Alma Cohen; Dan M. Fliss; Jacob T. Cohen πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 1 views

## Abstract Underreporting of swallowing disturbances by Parkinson's disease (PD) patients may lead to delay in diagnosis and treatment, alerting the physician to an existing dysphagia only after the first episode of aspiration pneumonia. We developed and validated a swallowing disturbance question

A comparison of sumanirole versus placeb
✍ Carlos Singer; Janice Lamb; Amanda Ellis; Gary Layton πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 1 views

## Abstract To assess the safety and efficacy of sumanirole, a highly selective dopamine agonist, versus placebo and demonstrate its noninferiority to ropinirole, 614 patients with early Parkinson's disease (PD) were treated with sumanirole, 1 to16 mg/day; ropinirole, 0.75 to 24 mg/day; or placebo.